New ‘vaccine-like’ HIV drug costing $54,000 could be made for just $54: Researchers
PARIS - A new “vaccine-like” HIV drug that currently costs over US$40,000 (S$54,000) per person a year could be made for as little as US$40, researchers estimated on July 23. The antiretroviral drug Lenacapavir, developed by US pharmaceutical giant Gilead, …